Skip to main content
Caplight Logo









Carterra

Carterra

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://carterra-bio.com/

Last Round

Series G

Dec 14, 2020

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Carterra is a biotechnology company that provides a high-throughput biosensor platform intended to accelerate the discovery of novel therapeutic candidates.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

High-Throughput Surface Plasmon ResonanceHT-SPRbiomolecular interaction analysishigh-throughput screeningdrug discovery platformantibody characterizationflow printing microfluidicslab instrumentationepitope analysiskinetics analysislife science toolsbiosensor chipsantibody screeningsmall molecule screeningAI for drug discoveryAI life science infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carterra Comparables

Compare Carterra with similar companies based on industry and business-model similarity.

Carterra comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nicoya Lifesciences Inc.
83%
Gator Bio
82%
NanoTemper Technologies
80%

Carterra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series GDec 14, 2020
VC RoundJan 14, 2020
VC RoundJan 17, 2018
VC RoundJul 1, 2014
VC RoundMay 30, 2012

Key People

Founding team and executive leadership

Tim Germann

Chief Commercial Officer

Executive Team

Carterra Investors

Notable investors and investment history

Carterra investors
InvestorRounds
Ballast Point VenturesSeries G, VC Round
Telegraph Hill PartnersVC Round, Series G
Park City AngelsVC Round
Pasadena AngelsVC Round
PfizerVC Round
TCA Venture GroupVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 51% MoM, reaching 11K.

  • Jan 31, 2026

    Monthly visitors increased 120% MoM, reaching 8.2K.

Carterra Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Carterra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carterra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range86
Year Founded2005
Last FundingDec 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?